Biopharmaceuticals generate global revenues of $163 billion, making up about 20 percent of the pharma market, according to McKinsey 2017. They also noted that patent filings are growing at a rate of 25% year on year.
Out of the customers we spoke to, 92% said they needed sophisticated tools to help them check freedom to operate and novelty for their biological sequences - that's why we built PatSnap Bio.
In this exclusive webinar, hosted by our Bio team here at PatSnap, we will be discussing:
- Critical challenges and needs within the biotechnology industry, identified by our customers
- The creation of PatSnap Bio, and the gap it fills for innovators in biotechnology.